Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Equilis StrepE   
Auth. number : EU/2/04/043
INN : Live Streptococcus equi strain TW928
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI05 - Immunologicals for equidae
Pharmacological subgroup: QI05A - Horse
Chemical subgroup: QI05AE - Live bacterial vaccines
Chemical substance: QI05AE - Live bacterial vaccines
(See WHO ATCvet Index)
Indication: for immunisation of horses against Streptococcus equi to reduce clinical signs and occurrence of lymph node abscesses
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/05/2004 Centralised - Authorisation EMEA/V/C/78 (2004)1822 of 07/05/2004
18/01/2007 Centralised - Variation EMEA/V/C/78/II/1 (2007)176 of 16/01/2007
07/02/2007 Centralised - Variation EMEA/V/C/78/IA/2
17/11/2008 Centralised - Variation EMEA/V/C/78/II/3
18/12/2008 Centralised - Variation EMEA/V/C/78/II/4, 5 (2008)8732 of 16/12/2008
29/04/2009 Centralised - Renewal EMEA/V/C/78/R/6 (2009)3367 of 27/04/2009
11/05/2010 Centralised - Variation EMEA/V/C/78/IAin/1/G
30/07/2013 Centralised - Variation EMEA/V/C/78/IB/8
Updated with Decision(2014)2592 of 10/04/2014
14/04/2014 Centralised - Renewal EMEA/V/C/78/R/10 (2014)2592 of 10/04/2014